Other
Neoplasm by Morphology
CI-CAN-00000002Explore in graph →
Non-malignant13,328 active trials222 approved drugs2,775 evidence items
- NCIt
- C4741
Loading cancer entity…
Other
CI-CAN-00000002Explore in graph →
Clinical trials
52,686 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00083460 | Study of Combination PS-341 and Thalidomide in Multiple Myeloma | completed | Phase 1 | 86 | University of ArkansasOTHER | 1 | Aug 2, 2010 | clinicaltrials |
| NCT01058785 | Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung Cancer | completed | Phase 2 | 75 | NovaRx CorporationINDUSTRY | 1 | Jul 29, 2010 | clinicaltrials |
| NCT01043302 |
| Multicenter Cross Sectional Study of Primary Intestine Lymphoma |
| completed |
| — |
| 545 |
| Samsung Medical CenterOTHER |
| 1 |
| Jul 28, 2010 |
| clinicaltrials |
| NCT00186381 | Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission | completed | Phase 2 | 200 | Stanford UniversityOTHER | 1 | Jul 27, 2010 | clinicaltrials |
| NCT00186394 | High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma | completed | Phase 2 | 35 | Stanford UniversityOTHER | 1 | Jul 27, 2010 | clinicaltrials |
| NCT00979342 | Comparative Sedation Study of the MyoSure Hysteroscopic Tissue Removal System | completed | N/A | 40 | Hologic, Inc.INDUSTRY | 1 | Jul 23, 2010 | clinicaltrials |
| NCT00612183 | Clinical Study on SyB L-0501 in Patients With Indolent B-cell Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma | completed | Phase 2 | 56 | SymBio PharmaceuticalsINDUSTRY | 1 | Jul 22, 2010 | clinicaltrials |
| NCT00572325 | Concurrent Chemo-radiation Form NSCLC to a Individualized MLD(BRONC CONC MLD) | completed | — | 180 | Maastricht Radiation OncologyOTHER | 1 | Jul 21, 2010 | clinicaltrials |
| NCT00573040 | Radiotherapy for NSCLC to a Individualized MLD(BRONC MLD) | completed | — | 180 | Maastricht Radiation OncologyOTHER | 1 | Jul 21, 2010 | clinicaltrials |
| NCT00547742 | Correlation of PET-CT Studies With Serum Protein Analysis | completed | — | 1,500 | Stanford UniversityOTHER | 1 | Jul 20, 2010 | clinicaltrials |
| NCT00129519 | A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence | completed | Phase 3 | 63 | Graceway Pharmaceuticals, LLCINDUSTRY | 1 | Jul 16, 2010 | clinicaltrials |
| NCT01160185 | Meta-analysis of Efficacy of Topotecan | completed | — | 1 | GlaxoSmithKlineINDUSTRY | 0 | Jul 12, 2010 | clinicaltrials |
| NCT00316225 | Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen | completed | Phase 2 | 31 | Eli Lilly and CompanyINDUSTRY | 3 | Jul 9, 2010 | clinicaltrials |
| NCT00794261 | Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma(PALM) | completed | Phase 2 | 150 | Centre Leon BerardOTHER | 1 | Jul 8, 2010 | clinicaltrials |
| NCT01157988 | 90Y-ibritumomab Tiuxetan Consolidation After 6th R-CHOP Chemotherapy in Patients With Bulky Diffuse Large B Cell Lymphoma | completed | Phase 2 | 20 | Chonnam National University HospitalOTHER | 1 | Jul 8, 2010 | clinicaltrials |
| NCT00083538 | Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally | completed | Phase 2 | 40 | University of ArkansasOTHER | 1 | Jul 7, 2010 | clinicaltrials |
| NCT00083408 | Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide | completed | Phase 2 | 20 | University of ArkansasOTHER | 1 | Jul 5, 2010 | clinicaltrials |
| NCT00083707 | Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia | completed | Phase 2 | 40 | University of ArkansasOTHER | 1 | Jul 5, 2010 | clinicaltrials |
| NCT01157013 | Role of Positron Emission Tomography in the Evaluation of Response to Sorafenib in Advanced Hepatocellular Carcinoma | completed | N/A | 40 | Hospital Miguel ServetOTHER | 1 | Jul 5, 2010 | clinicaltrials |
| NCT00081757 | An Open Protocol for the Compassionate Use of Thalidomide | completed | Phase 1 / Phase 2 | 250 | University of ArkansasOTHER | 1 | Jul 2, 2010 | clinicaltrials |
| NCT00083577 | Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma | completed | Phase 2 | 250 | University of ArkansasOTHER | 1 | Jul 2, 2010 | clinicaltrials |
| NCT00083681 | DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse | completed | Phase 2 | 180 | University of ArkansasOTHER | 1 | Jul 2, 2010 | clinicaltrials |
| NCT00083694 | Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia | completed | Phase 2 | 25 | University of ArkansasOTHER | 1 | Jul 2, 2010 | clinicaltrials |
| NCT00083876 | D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma | completed | Phase 3 | 500 | University of ArkansasOTHER | 1 | Jul 2, 2010 | clinicaltrials |
| NCT00083902 | Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy | completed | Phase 2 | 190 | University of ArkansasOTHER | 1 | Jul 2, 2010 | clinicaltrials |
| NCT00093028 | Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II | completed | Phase 3 | 315 | University of ArkansasOTHER | 1 | Jul 2, 2010 | clinicaltrials |
| NCT00193557 | Weekly Bortezomib (Velcade) in the Treatment of Patients With Refractory Multiple Myeloma | completed | Phase 2 | 40 | SCRI Development Innovations, LLCOTHER | 1 | Jun 29, 2010 | clinicaltrials |
| NCT00294931 | Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 50 | SCRI Development Innovations, LLCOTHER | 1 | Jun 28, 2010 | clinicaltrials |
| NCT00952874 | Molecular Biology of Anal Cancer in HIV-Positive Patients | completed | — | 30 | University Hospital, GenevaOTHER | 1 | Jun 25, 2010 | clinicaltrials |
| NCT00002517 | Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome | completed | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Jun 22, 2010 | clinicaltrials |
| NCT00074048 | BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell Leukemia | completed | Phase 2 | 36 | MedImmune LLCINDUSTRY | 1 | Jun 22, 2010 | clinicaltrials |
| NCT00126646 | BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma | completed | Phase 1 | 24 | MedImmune LLCINDUSTRY | 1 | Jun 22, 2010 | clinicaltrials |
| NCT00308529 | Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer | completed | Phase 2 | 55 | SCRI Development Innovations, LLCOTHER | 1 | Jun 22, 2010 | clinicaltrials |
| NCT00417911 | Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients | completed | Phase 3 | 400 | Nordic Myeloma Study GroupOTHER | 5 | Jun 22, 2010 | clinicaltrials |
| NCT00776074 | A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids. | completed | Phase 2 | 80 | TakedaINDUSTRY | 0 | Jun 22, 2010 | clinicaltrials |
| NCT01148446 | R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL(ANZINTER3) | completed | Phase 3 | 226 | Fondazione Italiana Linfomi - ETSOTHER | 1 | Jun 22, 2010 | clinicaltrials |
| NCT00006367 | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 3 | Jun 17, 2010 | clinicaltrials |
| NCT00614770 | Narrow Band Imaging Colon Polyp Study | completed | N/A | 630 | Kansas City Veteran Affairs Medical CenterFED | 1 | Jun 17, 2010 | clinicaltrials |
| NCT01145248 | Comparison of Biliary Forceps Biopsy and Brush Cytology | completed | N/A | 43 | University of UlmOTHER | 1 | Jun 16, 2010 | clinicaltrials |
| NCT00002588 | Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia | completed | Phase 1 | 30 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00003110 | Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma | completed | Phase 2 | 5 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00003114 | Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease | completed | Phase 2 | 5 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00003116 | High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer | completed | Phase 2 | 66 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00003336 | Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions | completed | Phase 2 | 6 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00005593 | Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome | completed | Phase 1 | 31 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00047021 | Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma | completed | Phase 2 | 3 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00049439 | Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma | completed | Phase 2 | 54 | Case Comprehensive Cancer CenterOTHER | 3 | Jun 11, 2010 | clinicaltrials |
| NCT00109993 | Campath-1H + FK506 and Methylprednisolone for GVHD | completed | Phase 2 | 34 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00028665 | Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma | completed | Phase 2 | 37 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT00053287 | Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS | completed | Phase 2 | 42 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
Data updated 24 days agoSource updated Aug 2, 2010source: clinicaltrials